Ownership

Rachel McMinn - Insider Trading & Ownership

Entity: Individual
Location: C/O Intercept Pharmaceuticals, Inc., 450 W. 15 Th St., Ste. 505, New York, NY
Summary: The estimated net worth of Rachel McMinn is at least $21.6M dollars as of March 28, 2025. Rachel McMinn is the Chief Executive Officer, Director of Neurogene Inc. and owns shares of Neurogene Inc. (NGNE) stock worth about $21.6M.
All Insider Reports: All Insider Reports

Ownership of Rachel McMinn

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
NGNE	Neurogene Inc.	Chief Executive Officer, Director	$21.6M	+$969K	+4.7%	Mar 26, 2025

Insider Transactions Reported by Rachel McMinn:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.